BPC-157 and Ipamorelin Interaction

Synergistic
Researched 95% confidence

BPC-157 and Ipamorelin have a synergistic interaction with 95% confidence. BPC-157 increases GH receptor expression, amplifying growth hormone benefits. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
Brain
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (BPC-157, Ipamorelin). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (BPC-157, Ipamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Ipamorelin?

Yes, BPC-157 and Ipamorelin can generally be taken together. BPC-157 increases GH receptor expression, amplifying growth hormone benefits.

Is BPC-157 and Ipamorelin safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Ipamorelin?

BPC-157 increases GH receptor expression, amplifying growth hormone benefits. This assessment has 95% confidence and is based on documented research data.

How should I time BPC-157 and Ipamorelin?

BPC-157 has a half-life of <30 minutes and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Ipamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.